Introducing AgentV: A Scalable Solution For 10X Exosome Yield

Traditional filtration methods achieve high protein clearance but result in significant particle loss, often retaining only 5-10% of extracellular vesicles through full downstream processing. This presentation examines the mechanisms behind filter fouling during clarification and tangential flow filtration steps, revealing why particle recovery decreases as impurities are removed. Learn how a novel treatment approach, AgentV, prevents filter fouling, increases loading capacity, and enables the use of smaller cutoff filters.

Understand how this solution maintains critical quality attributes including particle size distribution, canonical marker expression, and product potency. Find out how AgentV integrates into end-to-end manufacturing workflows and what options exist for companies without in-house downstream processing capabilities.